Skip to search formSkip to main contentSkip to account menu

FAM Regimen

Known as: Fluorouracil-Adriamycin-Mitomycin Regimen 
A regimen consisting of fluorouracil, doxorubicin and mitomycin used for the treatment of advanced-stage gastric and pancreatic cancer.
National Institutes of Health

Related topics

Related topics

6 relations
DoxorubicinFluorouracilMitomycinPancreatic carcinoma

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Clinical Observation on Composite Salviae Dropping Pill Combined with FAM Regimen in the Treatment of Gastric Carcinoma
Objective:To observe therapeutic effect of Composite Salviae Dropping Pill(CSDP), its influence on life quality and toxicity in… 
1996
1996
The combination of cisplatin, doxorubicin, and mitomycin (PAM) compared with the FAM regimen in treating advanced gastric carcinoma: A phase II randomized trial of the Italian oncology group for…
In a randomized Phase II study, the authors evaluated the activity and toxicity of the new cisplatin, doxorubicin, and mitomycin… 
1981
1981
The FAM regimen for gastric cancer: a progress report.
The FAM regimen for upper gastrointestinal cancer was developed during 1974. It incorporated three anticancer drugs which had… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)